Global Orthobiologics Market, By Product (Demineralized Bone Matrix {DBM}, Allograft, Bone Morphogenetic Protein {BPM}, Viscosupplementation Products, Synthetic Bone Substitutes and Others), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine, Others), and End-User (Hospitals and Ambulatory Centers, Research and Academic Institute, and Dental Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Orthobiologics Market
The orthobiologics market is expected to witness market growth at a rate of 5.9% in the forecast period of 2021 to 2028. Data Bridge Market Research report on orthobiologics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the geriatric and obese population is escalating the growth of orthobiologics market.
Orthobiologics can also be referred to as regenerative cellular therapies. Orthobiological products include development factors to enhance and stimulate the pain, tissue healing, and help in repairing ordinary functioning.
Major factors that are expected to boost the growth of the orthobiologics market in the forecast period are the rise in the prevalence of sports injuries and road accidents. Furthermore, the increase in the cases of spinal diseases and disorders is further anticipated to propel the growth of the orthobiologics market. Moreover, the increasing in the patient preference for minimally invasive procedures is further estimated to cushion the growth of the orthobiologics market. On the other hand, the rise in the cost regarding the orthobiologics-based treatments is further projected to impede the growth of the orthobiologics market in the timeline period.
In addition, the advancing countries will further provide potential opportunities for the growth of the orthobiologics market in the coming years. However, the harmful Effects regarding the Bmp-based treatments might further challenge the growth of the orthobiologics market in the near future.
This orthobiologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on orthobiologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Orthobiologics Market Scope and Market Size
The orthobiologics market is segmented on the basis of product, application, type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, orthobiologics market is segmented into demineralized bone matrix {DBM}, allograft, bone morphogenetic protein {BPM}, viscosupplementation products and synthetic bone substitutes and others.
- On the basis of application, the orthobiologics market is segmented into osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial & dental applications.
- On the basis of type, the orthobiologics market is segmented into knee, ankle, hip, wrist & shoulder, spine, and others.
- On the basis of end user, the orthobiologics market is segmented into hospitals and ambulatory centers, research and academic institute, and dental clinics.
Global Orthobiologics Market Country Level Analysis
The orthobiologics market is analysed and market size insights and trends are provided by country, product, application, type and end user as referenced above.
The countries covered in the orthobiologics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the orthobiologics market due to increase in the occurrence of the majority of the important players. Furthermore, the rise in the elderly population will further boost the growth of the orthobiologics market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the orthobiologics market due to increase in the physician consciousness levels. Moreover, the rise in the healthcare expenditure and disposable income is further anticipated to propel the growth of the orthobiologics market in the region in the coming years.
The country section of the orthobiologics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The orthobiologics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for orthobiologics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the orthobiologics market. The data is available for historic period 2010-2019.
Competitive Landscape and Global Orthobiologics Market Share Analysis
The orthobiologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to orthobiologics market.
The major players covered in the orthobiologics market report are XTANT MEDICAL, Arthrex, Inc., SeaSpine, NuVasive, Inc, Bioventus., Kuros Biosciences, K2M, Inc., RTI Surgical Holdings, Inc., Orthofix Holdings, Inc., Globus Medical Inc, Harvest Technologies, Zimmer Biomet, Stryker, Medtronic, DePuy Synthes, Sanofi, SEIKAGAKU CORPORATION, Musculoskeletal Transplant Foundation, dba MTF Biologics, Alphatec Spine, Inc. and Exactech, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-